Alkermes plc (ALKS)
NASDAQ: ALKS · Real-Time Price · USD
34.14
+0.41 (1.22%)
At close: Apr 28, 2026, 4:00 PM EDT
33.61
-0.53 (-1.55%)
After-hours: Apr 28, 2026, 7:04 PM EDT
Alkermes Employees
Alkermes had 2,050 employees as of December 31, 2025. The number of employees increased by 250 or 13.89% compared to the previous year.
Employees
2,050
Change (1Y)
250
Growth (1Y)
13.89%
Revenue / Employee
$719,951
Profits / Employee
$117,885
Market Cap
5.68B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Dr. Reddy's Laboratories | 27,811 |
| Elanco Animal Health | 9,900 |
| Amneal Pharmaceuticals | 8,700 |
| Hims & Hers Health | 2,442 |
| Neurocrine Biosciences | 2,000 |
| HUTCHMED (China) | 1,796 |
| Lantheus Holdings | 1,193 |
| Supernus Pharmaceuticals | 778 |
ALKS News
- 7 days ago - Alkermes to Report First Quarter Financial Results on May 5, 2026 - Business Wire
- 12 days ago - Alkermes to Present Additional Data From Vibrance-1 Phase 2 Study of Alixorexton in Patients with Narcolepsy Type 1 at the American Academy of Neurology (AAN) 2026 Annual Meeting - Business Wire
- 14 days ago - Findings From Long-Term Analysis of the Effects of LYBALVI® (olanzapine and samidorphan) on Negative Symptoms of Schizophrenia Published in The Journal of Clinical Psychiatry - Business Wire
- 27 days ago - Top 2 Health Care Stocks That May Implode In April - Benzinga
- 27 days ago - Alkermes Announces Initiation of Phase 3 Brilliance Studies Evaluating Alixorexton for the Treatment of Narcolepsy Type 1 and Type 2 - Business Wire
- 6 weeks ago - Alkermes Transcript: Stifel 2026 Virtual CNS Forum - Transcripts
- 6 weeks ago - Alkermes Announces Inaugural Alkermes Pathways APN Research Awards™ Program - Business Wire
- 7 weeks ago - Alkermes to Present at the Stifel 2026 Virtual CNS Forum - Business Wire